Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy.
JinHui LiuYuanyuan WangJian YinYan YangRui GengZihang ZhongSenmiao NiWen LiuMulong DuHao YuJianling BaiPublished in: Journal of oncology (2022)
may be a new biomarker for the prognosis and immunotherapy in various cancers. As a result, it will be beneficial to provide new therapies for cancer patients, thereby improving the treatment and prognosis of cancer patients.